About

As Executive Vice President, Chief Operations Officer, Dr. Azita Saleki-Gerhardt leads a global team of scientific, manufacturing, engineering, quality and supply chain professionals responsible for the supply and distribution of all AbbVie products, along with enterprise services including facilities, purchasing and security. She joined Abbott in 1993 as a research scientist and assumed the role of President, Global Pharmaceutical Operations at Abbott in 2011 before being appointed to lead Operations at AbbVie following the 2013 separation.

She also serves as chair of AbbVie's executive crisis management team, responsible for the company's cross-functional preparedness and response.

Roles

AbbVie Inc.
Executive Vice President, Chief Operations Officer · Current role
Dec 2012–present
AbbVie
Executive Vice President, Operations
2018 - Jul 2023
AbbVie
Senior Vice President, Operations
2013 - 2018
Abbott
Vice President, Pharmaceuticals Manufacturing and Supply
2011 - 2012
Abbott
Divisional Vice President, Quality Assurance, Global Pharmaceutical Operations · Joined Abbott in 1993
2008 - 2011
Abbott
President, Global Pharmaceutical Operations · Assumed role in 2011
Abbott
Research scientist · Joined Abbott in 1993

External Roles

Entegris Inc.
Director

Fixed Compensation

FY 2025
Base Salary
$1,052,581
Change in Pension Value & Nonqualified Deferred Compensation Earnings
$1,778,878
All Other Compensation
$820,310

Performance Compensation

Data from FY 2025

Cash incentive

Annual Cash Incentive (Non-Equity Incentive Plan Compensation)
$2,200,000
Target Opportunity
ProgramAbbVie annual cash incentive plan

Stock awards

Stock Awards (grant-date fair value)
$3,980,457
VehiclesPerformance shares (EPS + relative TSR, 0-250% of target) and performance-vested RSUs (relative ROIC, 0-200% of target)
2025 resultAdjusted diluted EPS performance banked the 2025 performance-share award at 200% of target (TSR-modified vesting through Dec 31, 2027); relative ROIC vested one-third of the PVRSU award at 200% of target
Option Awards (grant-date fair value)
$959,750
VestingOne-third after each of years one, two and three of service

Also at AbbVie Inc.

Related

See how VectorShift works for your firm

Request Demo